Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -14.25
- Piotroski Score 2.00
- Grade Buy
- Symbol (INAB)
- Company IN8bio, Inc.
- Price $0.32
- Changes Percentage (-1.16%)
- Change -$0
- Day Low $0.31
- Day High $0.33
- Year High $2.48
IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of glioblastoma and solid tumors; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with acute leukemia undergoing hematopoietic stem cell transplantation. It also develops INB-400 and INB-300 that is in preclinical Phase for treatment of various solid tumor cancers. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/13/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.90
- Trailing P/E Ratio -1.49
- Forward P/E Ratio -1.49
- P/E Growth -1.49
- Net Income $-30,007,000
Income Statement
Quarterly
Annual
Latest News of INAB
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Mercedes reinventing cars' brakes, eyeing sustainability, health benefits
Automakers are advancing software-defined vehicles with sustainable technologies to move towards an emissions-free future. Recent studies show braking systems emit more pollutants than tailpipes, prom...
By Newsweek | 1 day ago -
'Tsunami: Race Against Time' Revisits A Day Of Unimaginable Tragedy
The deadliest tsunami in history occurred on December 26, 2004, reshaping global awareness of natural disasters....
By Forbes | 1 day ago -
US Debt Sustainability Now Seen as Top Financial Stability Risk
The US government's debt is now the top concern for financial stability, according to a Federal Reserve survey. Other risks include Middle East tensions and policy uncertainty. The report highlights h...
By Yahoo! Finance | 1 day ago
